Biblio Discovery — Demo Discovery Service

58 hasil untuk "Maria E Suarez-Almazor"

Menampilkan 1–20 · 0,27 detik · RSS

  1. Artikel Jurnal

    The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy

    Sebastian Bruera; Maria E. Suarez-Almazor

    Frontiers in Oncology, Vol. 12 · 2022 · Inggris · DOAJ Scopus

    The emergence of checkpoint inhibitors has created a paradigm shift for the treatment of various malignancies. However, although these therapies are associated with improved survival rates, they also carry the risk of immune-related adverse events (irAEs). Moderate to severe irAEs are typically…

  2. Artikel Jurnal Teks lengkap

    Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports

    Noha Abdel-Wahab; Mohsin Shah; Maria E. Suarez-Almazor

    PLOS ONE, Vol. 11 No. 7 · 2016 · Inggris · PLOS Scopus

    Background: Three checkpoint inhibitor drugs have been approved by the US Food and Drug Administration for use in specific types of cancers. While the results are promising, severe immunotherapy-related adverse events (irAEs) have been reported. Objectives: To conduct a systematic review of case…

    Juga tersedia di: DOAJ

  3. Artikel Jurnal Teks lengkap

    Rheumatic and Musculoskeletal Adverse Events with Immune Checkpoint Inhibitors: Data from the United States Food and Drug Administration Adverse Event Reporting System

    Xerxes N Pundole; Mayur Sarangdhar; Maria E Suarez-Almazor

    Journal of Immunotherapy and Precision Oncology, Pp 65-73 (2019) · 2019 · Inggris · DOAJ Scopus

    Background: Despite their efficacy, immune checkpoint inhibitors (ICIs) can cause significant immune-related adverse events (irAEs). Rheumatic and musculoskeletal irAEs can be serious and adversely affect the quality of life. The full spectrum of irAEs is still emerging, and to represent and better…

  4. Artikel Jurnal

    Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare

    Hyun J. Kim; Amado J. Zurita; Maria E. Suarez-Almazor

    Journal for ImmunoTherapy of Cancer, Vol. 7 No. 1 · 2019 · Inggris · DOAJ Scopus

    BackgroundDespite ground-breaking clinical success in the treatment of different cancers, immune checkpoint inhibitors can cause profound inflammatory and immune-related adverse events. Autoimmune inflammatory arthritis following immune checkpoint inhibitor treatment has been reported; however, to…

  5. Artikel Jurnal Teks lengkap

    Expert Clinical Management of Inflammatory Immune-Related Arthritis in Patients with Cancer Receiving Immune Checkpoint Inhibitors

    Sebastian Bruera; Mar Riveiro-Barciela; Alexa Meara dkk.

    Journal of Immunotherapy and Precision Oncology, Vol. 8 No. 1 · 2025 · Inggris · DOAJ Scopus

    Introduction Treatment guidelines for immune-related inflammatory arthritis (irAE-IA) in patients with cancer receiving immune checkpoint inhibitors (ICIs) are vague with respect to the use of specific agents. Patients are usually referred to rheumatologists for treatment. We conducted a survey of…

  6. Artikel Jurnal Teks lengkap

    COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review

    Juan I. Ruiz; Maria A. Lopez-Olivo; Yimin Geng dkk.

    Journal of Immunotherapy and Precision Oncology, Vol. 6 No. 2 · 2023 · Inggris · DOAJ Scopus

    Introduction: Immune checkpoint inhibitors (ICIs) can cause inflammatory and immune-related adverse events (irAEs) that might worsen the course of COVID-19. We conducted a systematic review (PROSPERO ID: CRD42022307545) to evaluate the clinical course and complications of COVID-19 in patients with…

  7. Artikel Jurnal

    COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis

    Maria E Suarez-Almazor; Juan Ignacio Ruiz; Maria Angeles Lopez-Olivo dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 11 No. 2 · 2023 · Inggris · DOAJ Scopus

    Background Immune checkpoint inhibitors (ICI) can cause off-target inflammatory and immune-related adverse events (irAE). Conceivably, COVID-19 vaccination could trigger an inflammatory and immune response that could induce or aggravate irAE.Methods The objective of this systematic review is to…

  8. Artikel Jurnal Teks lengkap

    Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies

    Jude des Bordes; Seema Prasad; Greg Pratt dkk.

    PLOS ONE, Vol. 15 No. 1 · 2020 · Inggris · PLOS Scopus

    Background: Patients with low bone density or osteoporosis need information for effective prevention or disease management, respectively. However, patients may not be getting enough information from their primary care providers or other sources. Inadequate disease information leaves patients…

    Juga tersedia di: DOAJ

  9. Artikel Jurnal

    Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis

    Juan Sevillano; Noha Abdel‐Wahab; Yixuan Zhou dkk.

    ACR Open Rheumatology, Vol. 8 No. 3 · 2026 · Inggris · DOAJ Scopus

    Objective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials. We aimed to evaluate the frequency, severity, and outcomes of…

  10. Artikel Jurnal Teks lengkap

    A comprehensive scoping review to identify standards for the development of health information resources on the internet

    Noha Abdel-Wahab; Devesh Rai; Harish Siddhanamatha dkk.

    PLOS ONE, Vol. 14 No. 6 · 2019 · Inggris · PLOS Scopus

    Background: Online health information, if evidence-based and unbiased, can improve patients’ and caregivers’ health knowledge and assist them in disease management and health care decision-making. Objective: To identify standards for the development of health information resources on the internet…

    Juga tersedia di: DOAJ

  11. Artikel Jurnal Teks lengkap

    Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan

    Juan Ignacio Ruiz; Gagandeep Singh; McKenna Erck dkk.

    PLOS ONE, Vol. 17 No. 10 · 2022 · Inggris · PLOS Scopus

    Background: Trustworthy educational information for patients is critical for increasing their knowledge base and preparing them for shared decision making with clinicians. As the internet has become an important source of health information for many patients, the purpose of this study was to assess…

    Juga tersedia di: DOAJ, DOAJ

  12. Artikel Jurnal

    Beliefs, preferences, and informational needs of patients with rheumatoid arthritis and concomitant cancer: a qualitative study

    Juan I. Ruiz; Sheneze T. Madramootoo; Maria A. Lopez-Olivo dkk.

    BMC Rheumatology, Vol. 9 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Background Treatment of rheumatoid arthritis (RA) with biologic drugs in patients with cancer could potentially result in poor cancer outcomes. This study aimed to identify the beliefs, preferences, and informational needs of patients with RA and cancer regarding the harms, benefits, and…

  13. Artikel Jurnal Teks lengkap

    Major Adverse Cardiovascular Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors

    Juan I. Ruiz; Bo Zhao; Nicolas Palaskas dkk.

    Journal of Immunotherapy and Precision Oncology, Vol. 8 No. 2 · 2025 · Inggris · DOAJ Scopus

    Introduction Immune checkpoint inhibitors (ICIs) might increase the risk of major adverse cardiovascular events (MACEs). This study aimed to evaluate the risk of MACE in patients with melanoma after ICI initiation. Methods We conducted a before-after cohort study using claims data from Optum’s…